Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03401450 · ClinicalTrials.gov registry record · Phase 4
Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 69
- Enrollment target
NCT03401450 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 69 participants.
The verdict
NCT03401450, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 69 participants
- Enrollment target
Study Summary
This is a prospective, randomized, single blinded trial involving human subjects. The goal of this study is to determine an optimal location (proximal or distal) for the nerve block and whether it will make a difference in how much opioid the patient will receive during and after surgery. Ultrasound will identify the adductor canal and the proximal end of the adductor canal/apex of the femoral triangle to determine the location of the blocks. Their will be two randomized groups: 1. ACB within true AC with bupivacaine 0.5% 20cc2. ACB proximal to true AC with bupivacaine 0.5% 20cc
Interventions
- DRUG ACB within true AC with bupivacaine 0.5% 20cc
- DRUG ACB proximal to true AC with bupivacaine 0.5% 20cc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2021-06-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03401450
The ClinicalTrials.gov registry entry for NCT03401450 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACB within true AC with bupivacaine 0.5% 20cc is the first listed.
NCT03401450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03401450 about?
NCT03401450 is a clinical study titled "Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block". This is a prospective, randomized, single blinded trial involving human subjects. The goal of this study is to determine an optimal location (proximal or distal) for the nerve block and whether it will make a difference in how much opioid the patient will receive during and after surgery. Ultrasound...
What is the current status of trial NCT03401450?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2018-02-01. Estimated completion is 2021-06-29.
What interventions are being tested in trial NCT03401450?
The interventions under investigation include: ACB within true AC with bupivacaine 0.5% 20cc (DRUG), ACB proximal to true AC with bupivacaine 0.5% 20cc (DRUG).
Who is sponsoring clinical trial NCT03401450?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.